Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD) - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

September 7, 2007

Last Updated Date

September 10, 2007

Start Date ^†

January 2006

Current Primary Outcome Measures ^†

Original Primary Outcome Measures ^†

Change History

Complete list of historical versions of study NCT00527709 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)

Official Title ^†

Brief Summary

This pilot study is being pursued to observe whether certain medications are given to patients within a timeframe where their being given could play a part in a critical event in the management of the patient. There are general rules about when it would be appropriate for these types of medications not to be given. However, it is not current standard practice for the criteria to be put in place without the expressed wishes of the ordering physician or their agent.

Research Question:

Can the administration of cardio-depressant medications be documented as a significant risk factor for hypotensive or bradycardic events?

Detailed Description

Study Phase

Study Type ^†

Observational

Study Design ^†

Natural History, Cross-Sectional, Convenience Sample, Retrospective Study

Condition ^†

Asystole
Bradycardia
Hypotension

Intervention ^†

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Active, not recruiting

Enrollment ^†

Completion Date

August 2006

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

Serial evaluation of the first 50 documented events of Code Blue or call to Rapid Response Team involving hypotension, bradycardia or asystole in the adult inpatient population events beginning January 1, 2006.

Gender

Both

Ages

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

United States

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00527709

Responsible Party

Secondary IDs ^††

Study Sponsor ^†

Hackensack University Medical Center

Collaborators ^††

Investigators ^†

Principal Investigator:

Amit Tailor, MD, MBA

Hackensack University Medical Center

Information Provided By

Hackensack University Medical Center

Verification Date

August 2006

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.